Roquefort Therapeutics

Industry: BIOTECHNOLOGY

ROQUEFORT THERAPEUTICS PLC (LSE: ROQ) is a public company listed on the Main Market of the London stock exchange. Roquefort is a biotechnology company developing innovative cancer medicines in the high growth oncology market. Led by CEO AJAN REGINALD, Roquefort has portfolio of four pre-clinical anti-cancer drugs and 46 registered patents.

Visited 115 times, 1 visit(s) today
Close Search Window
Close